Kamia Punia

Title: Kamia Punia: Innovator in Viral Detection and Therapeutics

Introduction

Kamia Punia is a notable inventor based in Staten Island, NY (US). She has made significant contributions to the field of viral detection and therapeutics, particularly in relation to SARS-CoV-2 and other diseases. Her innovative work has the potential to impact public health and medical diagnostics.

Latest Patents

Kamia Punia holds a patent for a groundbreaking invention titled "Therapeutics and point of care lateral-flow test for virus and antibodies using tagged assembled proteins." This patent features a multivalent protein designed to target the interaction between the SARS-CoV-2 spike receptor binding domain (RBD) and the human angiotensin-converting enzyme 2 (ACE2) receptor protein. Additionally, the multivalent proteins may be utilized to treat subjects suffering from cancer, viral infections, and other diseases. The invention also includes multiplex lateral flow test strips that allow for the simultaneous detection of the virus and viral antibodies.

Career Highlights

Kamia Punia is affiliated with New York University, where she continues her research and development in the field of therapeutics and diagnostics. Her work is characterized by a commitment to advancing medical technology and improving patient outcomes.

Collaborations

Kamia collaborates with esteemed colleagues such as Jin Kim Montclare and Farbod Mahmoudinobar, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Kamia Punia's contributions to the field of viral detection and therapeutics exemplify her dedication to advancing healthcare solutions. Her innovative patent and collaborative efforts position her as a key figure in the ongoing fight against viral infections and related diseases.